Lonza Group Ltd
1LONN
Company Profile
Business description
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Contact
Muenchensteinerstrasse 38
Basel4002
CHET: +41 613168111
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
18,686
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,820.30 | 6.40 | -0.07% |
| CAC 40 | 7,826.31 | 75.94 | -0.96% |
| DAX 40 | 24,244.77 | 212.04 | -0.87% |
| Dow JONES (US) | 44,344.45 | 306.19 | -0.69% |
| FTSE 100 | 8,935.82 | 39.84 | -0.44% |
| HKSE | 24,139.57 | 111.20 | 0.46% |
| NASDAQ | 20,585.01 | 45.65 | -0.22% |
| Nikkei 225 | 39,569.68 | 76.68 | -0.19% |
| NZX 50 Index | 12,686.68 | 73.52 | -0.58% |
| S&P 500 | 6,254.66 | 25.80 | -0.41% |
| S&P/ASX 200 | 8,580.10 | 9.10 | -0.11% |
| SSE Composite Index | 3,510.18 | 0.50 | 0.01% |